CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.430
-0.120 (-4.71%)
At close: Sep 18, 2026, 4:00 PM EDT
2.440
+0.010 (0.41%)
After-hours: Sep 18, 2026, 7:46 PM EDT
CervoMed Employees
CervoMed had 15 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$22,086
Profits / Employee
-$2,023,316
Market Cap
36.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 0 | - |
| Dec 31, 2024 | 15 | 7 | 87.50% |
| Dec 31, 2023 | 8 | 4 | 100.00% |
| Mar 31, 2023 | 4 | - | - |
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Celularity | 115 |
| Metagenomi Therapeutics | 113 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| Actinium Pharmaceuticals | 27 |
| Veru Inc. | 20 |
| Filana Therapeutics | 20 |
CRVO News
- 4 days ago - CervoMed Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 8 days ago - CervoMed Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 9 days ago - CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026 - GlobeNewsWire
- 11 days ago - CervoMed to Participate in September Investor Conferences - GlobeNewsWire
- 4 weeks ago - CervoMed price target lowered to $7 from $9 at Roth Capital - TheFly
- 5 weeks ago - CervoMed Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 weeks ago - CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 5 weeks ago - CervoMed price target lowered to $18 from $27 at Canaccord - TheFly